Alexander Y Tokman
CIK 1334483 · Chief Executive Officer · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MVIS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6222 185TH AVENUE NE
REDMOND, WA 98052
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NDRA | Chief Executive Officer | 101,926 | $4.78 | $487.2K | $26.5K | 7 | 2026-03-04 |
| ENDRA Life Sciences Inc. (NDRAW) Delisted | Director | 32,857 | $0.03 | $986 | -$9.0K | 12 | 2022-03-30 |
| MVIS | President and CEO | 12,048 | $1.14 | $13.7K | $113.0K | 9 | 2017-02-09 |
| MICROVISION, INC. (MVIS.W) Delisted | President and CEO | 84,902 | — | — | $0 | 1 | 2013-04-30 |
| MICROVISION, INC. (MVISW) Delisted | President and CEO | 86,391 | — | — | $91.7K | 19 | 2012-08-07 |
Recent Filings · Page 2 of 5
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-25 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-08 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Sell (S) | −10,000 | -$9.0K | EDGAR |
| 2020-04-13 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | +42,857 | $0 | EDGAR |
| 2020-01-06 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-27 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-04 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-23 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-18 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-09 | MVIS | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.